ERMAP and Alzheimer disease: 3XTg-AD mice aged 12 months, an age of advanced cerebral pathology, were injected intraperitoneally (i.p.)with anti-ERMAP mAb or isotype Ab (50 μg or 100 μg per mouse) once a week for 3 months.